| Serial Number | 87892837 |
| Word Mark | CASI |
| Filing Date | Wednesday, April 25, 2018 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Monday, March 31, 2025 |
| Registration Number | 5748674 |
| Registration Date | Tuesday, May 14, 2019 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, February 26, 2019 |
| Translation of Words in Mark | The English translation of the word "CASI" in the mark is "ALMOST". |
| Goods and Services | Pharmaceutical research and development; development of pharmaceutical preparations and medicines; provision of scientific information via Internet portals in the field of medical research and biotechnology; Product development research and product development in the field of pharmaceutical, biological and biotechnological products; medical research and product development services in the field of treatments for cancer, cardiovascular, metabolic, inflammatory, nervous system, anti-infective, and dermatological conditions; pharmaceutical research and development of human therapeutics using gene editing; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Research and development in the pharmaceutical and biotechnology fields; Research and development of new products; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research on the subject of pharmaceuticals; Biochemical research and development; Biological research; Biomedical research services; Clinical research in the field of cancer; Conducting clinical trials for others in the field of cancer; Conducting early evaluations in the field of new pharmaceuticals; Genotyping services for research or analysis purposes; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research, namely, conducting clinical trials for others; Pharmaceutical research services; Product research and development; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research; Scientific research and development; Stem cell research; Technical research in the field of pharmaceutical studies |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, May 4, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Monday, June 16, 2014 |
| First Use In Commerce Date | Monday, June 16, 2014 |
| Party Name | CASI PHARMACEUTICALS, INC. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
| Party Name | CASI PHARMACEUTICALS, INC. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
| Party Name | CASI PHARMACEUTICALS, INC. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Rockville, MD 20850 |
| Event Date | Event Description |
| Tuesday, May 1, 2018 | TEAS VOLUNTARY AMENDMENT RECEIVED |
| Sunday, May 6, 2018 | ASSIGNED TO LIE |
| Saturday, April 28, 2018 | NEW APPLICATION ENTERED |
| Friday, May 4, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 16, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, May 9, 2018 | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED |
| Thursday, August 16, 2018 | ASSIGNED TO EXAMINER |
| Thursday, August 16, 2018 | NON-FINAL ACTION WRITTEN |
| Thursday, August 16, 2018 | NON-FINAL ACTION E-MAILED |
| Thursday, August 16, 2018 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, January 16, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, January 16, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 16, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 6, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, February 26, 2019 | PUBLISHED FOR OPPOSITION |
| Tuesday, February 26, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 14, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Thursday, December 12, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Monday, March 31, 2025 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Monday, March 31, 2025 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Monday, March 31, 2025 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |
| Tuesday, May 14, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |